{
    "clinical_study": {
        "@rank": "89243", 
        "brief_summary": {
            "textblock": "To evaluate and compare the long-term (48-177 weeks) safety, tolerance, and efficacy of two\n      doses of zalcitabine ( dideoxycytidine; ddC ) taken orally every 8 hours in children with\n      symptomatic HIV infection who have one of the following: intolerance to zidovudine ( AZT )\n      (development of toxicity during prolonged AZT therapy), demonstrated disease progression\n      after 6 months of AZT therapy, OR both AZT intolerance and disease progression after 6\n      months of AZT therapy.\n\n      As useful as AZT appears to be in the treatment of patients infected with HIV, it is\n      associated with significant toxicity in some patients, and it does not prevent ultimate\n      progression to AIDS and eventual mortality. Thus, there is a clear need for new\n      antiretroviral drugs, and ddC is one such promising agent."
        }, 
        "brief_title": "A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT", 
        "completion_date": {
            "#text": "June 1995", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "As useful as AZT appears to be in the treatment of patients infected with HIV, it is\n      associated with significant toxicity in some patients, and it does not prevent ultimate\n      progression to AIDS and eventual mortality. Thus, there is a clear need for new\n      antiretroviral drugs, and ddC is one such promising agent.\n\n      Patients receive oral ddC for 48 to 177 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Procrit.\n\n          -  Amphotericin B (1 mg/kg up to 5 days/week).\n\n          -  Prophylaxis treatment as per ACTG recommendations for Pneumocystis carinii pneumonia.\n\n          -  Acyclovir (up to 1000 mg/day PO; for > 1000 mg/day PO or for any IV dose, suggest\n             interrupting ddC).\n\n          -  Ketoconazole (up to 10 mg/kg/day).\n\n          -  Nystatin.\n\n          -  Aspirin, acetaminophen, sedatives, and barbiturates (for up to 72 hours).\n\n          -  Isoniazid (INH), if there is no evidence of peripheral neuropathy at entry. Children\n             should receive pyridoxine, 25\n\n          -  50 mg/day to avoid possible INH-associated neuropathy.\n\n          -  Trimethoprim / sulfamethoxazole (T/S).\n\n          -  Immunoglobulin therapy.\n\n          -  Aerosolized pentamidine.\n\n          -  Drugs with little nephro-, hepato-, cytotoxicity that the patient has been taking and\n             tolerating well for an ongoing condition.\n\n        Concurrent Treatment:\n\n        Allowed:\n\n          -  Immunoglobulin therapy.\n\n          -  Nutritional support (for children with wasting syndrome and/or malnutritional)\n             including hyperalimentation (TPN) of dietary supplements.\n\n        AMENDED:\n\n          -  Patients enrolled in ACTG 051 may participate in ACTG 138 if they show intolerance to\n             AZT or show disease progression after 6 months of AZT therapy and meet entry criteria\n             for the study.\n\n        ORIGINAL design:\n\n          -  Patients enrolled in ACTG protocols 051 or 128 must meet study end points or meet\n             protocol definitions for being permanently off zidovudine (AZT) before enrolling in\n             this protocol.\n\n        Patients must have the following:\n\n          -  Absence of acute opportunistic infection at time of entry.\n\n          -  However, if patient is successfully treated for opportunistic infection and has\n             remained stable for 2 weeks after treatment, the patient is then allowed to enter the\n             study. Children receiving maintenance therapy for > 4 weeks are eligible.\n\n          -  Parent or guardian available to give written informed consent.\n\n        Allowed at time of study entry:\n\n          -  Prophylaxis treatment as per ACTG recommendations, for Pneumocystis carinii pneumonia\n             (PCP).\n\n          -  Immunoglobulin therapy.\n\n        Prior Medication:\n\n        AMENDED:\n\n          -  AZT or ddI up until study entry, other antiretrovirals up until 4 weeks of study\n             entry\n\n        Allowed:\n\n          -  Zidovudine (AZT) within 4 weeks of entry.\n\n          -  Dideoxyinosine (ddI) within 43 weeks of entry if no peripheral neuropathy has been\n             observed while receiving ddI.\n\n          -  Other toxicities observed while on ddI must resolve to level 2 or better before\n             patient can begin treatment with ddC.\n\n          -  Vitamin, folate, iron supplements.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        AMENDED:\n\n          -  04-25-91 Additional excluded symptoms and conditions:\n\n          -  Symptomatic cardiomyopathy.\n\n          -  Seizures which are not well controlled by ongoing anticonvulsant therapy.\n\n          -  Active malignancy requiring concomitant chemotherapy.\n\n          -  Symptomatic pancreatitis.\n\n          -  Grade I or greater peripheral neuropathy.\n\n          -  Receiving concomitant zidovudine (AZT).\n\n          -  Patients with the following conditions or symptoms are excluded:\n\n          -  Acute bacterial infections requiring IV or oral antibiotic treatment at time of\n             entry.\n\n          -  Known hypersensitivity to dideoxycytidine (ddC).\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Other antiviral agents, biological modifiers, and investigational medications.\n\n          -  Drugs with potential to cause peripheral neuropathy, including chloramphenicol,\n             iodoquinol, phenytoin, ethionamide, gold, ribavirin, vincristine, cisplatin, dapsone,\n             disulfiram, glutethimide, hydralazine, metronidazole, nitrofurantoin.\n\n        Patients with the following are excluded:\n\n          -  Acute bacterial infections requiring IV or oral antibiotic treatment at time of\n             entry.\n\n          -  Known hypersensitivity to dideoxycytidine (ddC).\n\n          -  Active opportunistic infection requiring treatment with an excluded concomitant\n             medication.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Antiretroviral agents (other than zidovudine (AZT) or didanosine (ddI)) within 4\n             weeks of entry.\n\n          -  Immunomodulating agents such as interferons, isoprinosine, or interleukin-2 within 2\n             weeks of entry.\n\n          -  Any other experimental therapy, drugs that cause prolonged neutropenia, significant\n             nephrotoxicity, or peripheral neuropathy within 1 week of entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "3 Months"
        }, 
        "enrollment": "140", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000653", 
            "org_study_id": "ACTG 138", 
            "secondary_id": "11113"
        }, 
        "intervention": {
            "intervention_name": "Zalcitabine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Zalcitabine"
        }, 
        "keyword": [
            "Zalcitabine", 
            "Drug Evaluation", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex"
        ], 
        "lastchanged_date": "March 29, 2012", 
        "link": {
            "description": "Click here for more information about Zalcitabine", 
            "url": "http://aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?MenuItem=Drugs&Search=On&int_id=15"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095"
                    }, 
                    "name": "UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oakland", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94609"
                    }, 
                    "name": "Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92093"
                    }, 
                    "name": "UCSD Maternal, Child, and Adolescent HIV CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Francisco", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94143"
                    }, 
                    "name": "UCSF Pediatric AIDS CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20010"
                    }, 
                    "name": "Children's National Med. Ctr., ACTU"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33161"
                    }, 
                    "name": "Univ. of Miami Ped. Perinatal HIV/AIDS CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30303"
                    }, 
                    "name": "Emory Univ. School of Medicine, Dept. of Peds., Div. of Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60614"
                    }, 
                    "name": "Chicago Children's CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Cook County Hosp."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Univ. of Illinois College of Medicine at Chicago, Dept. of Peds."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Orleans", 
                        "country": "United States", 
                        "state": "Louisiana"
                    }, 
                    "name": "Tulane/LSU Maternal/Child CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21201"
                    }, 
                    "name": "Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21287"
                    }, 
                    "name": "Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "HMS - Children's Hosp. Boston, Div. of Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02118"
                    }, 
                    "name": "BMC, Div. of Ped Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01199"
                    }, 
                    "name": "Baystate Health, Baystate Med. Ctr."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01655"
                    }, 
                    "name": "WNE Maternal Pediatric Adolescent AIDS CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Brunswick", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "UMDNJ - Robert Wood Johnson"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bronx", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10456"
                    }, 
                    "name": "Bronx-Lebanon Hosp. IMPAACT CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brooklyn", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11203"
                    }, 
                    "name": "SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Great Neck", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "North Shore-Long Island Jewish Health System, Dept. of Peds."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Hyde Park", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11042"
                    }, 
                    "name": "Schneider Children's Hosp., Div. of Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10037"
                    }, 
                    "name": "Harlem Hosp. Ctr. NY NICHD CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10016"
                    }, 
                    "name": "NYU Med. Ctr., Dept. of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10032"
                    }, 
                    "name": "Columbia IMPAACT CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10029"
                    }, 
                    "name": "Metropolitan Hosp. NICHD CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14642"
                    }, 
                    "name": "Univ. of Rochester ACTG CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27599"
                    }, 
                    "name": "UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }, 
                    "name": "DUMC Ped. CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19134"
                    }, 
                    "name": "St. Christopher's Hosp. for Children"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Texas Children's Hosp. CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bayamon", 
                        "country": "Puerto Rico", 
                        "zip": "00619"
                    }, 
                    "name": "Univ. Hosp. Ram\u00f3n Ruiz Arnau, Dept. of Peds."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Juan", 
                        "country": "Puerto Rico"
                    }, 
                    "name": "San Juan City Hosp. PR NICHD CRS"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Juan", 
                        "country": "Puerto Rico", 
                        "zip": "00936"
                    }, 
                    "name": "Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT", 
        "overall_official": {
            "last_name": "Spector SA", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "reference": [
            {
                "PMID": "21037891", 
                "citation": "Perrier M, Schwarz T, Gonzalez O, Brounts S. Squamous cell carcinoma invading the right temporomandibular joint in a Belgian mare. Can Vet J. 2010 Aug;51(8):885-7."
            }, 
            {
                "citation": "Spector SA, Blanchard S, Connor EM, Salgo MP, McNamara J. Results of a clinical trial comparing two doses of 2'3'-dideoxycytidine (ddC) in the treatment of children with symptomatic human immunodeficiency virus (HIV) infection who were intolerant or had failed zidovudine (ZDV) therapy (ACTG 138). The Pediatric AIDS Clinical Trials Group. American Pediatric Society 104th annual meeting and Society for Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle. Pediatr AIDS HIV Infect. 1994 Oct;5(5):323 (unnumbered abstract)"
            }
        ], 
        "removed_countries": {
            "country": "Puerto Rico"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000653"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "collaborator": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2012"
    }, 
    "geocoordinates": {
        "BMC, Div. of Ped Infectious Diseases": "42.358 -71.06", 
        "Baystate Health, Baystate Med. Ctr.": "42.101 -72.59", 
        "Bronx-Lebanon Hosp. IMPAACT CRS": "40.85 -73.867", 
        "Chicago Children's CRS": "41.878 -87.63", 
        "Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab.": "37.804 -122.271", 
        "Children's National Med. Ctr., ACTU": "38.895 -77.036", 
        "Columbia IMPAACT CRS": "40.714 -74.006", 
        "Cook County Hosp.": "41.878 -87.63", 
        "DUMC Ped. CRS": "35.994 -78.899", 
        "Emory Univ. School of Medicine, Dept. of Peds., Div. of Infectious Diseases": "33.749 -84.388", 
        "HMS - Children's Hosp. Boston, Div. of Infectious Diseases": "42.358 -71.06", 
        "Harlem Hosp. Ctr. NY NICHD CRS": "40.714 -74.006", 
        "Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases": "39.29 -76.612", 
        "Metropolitan Hosp. NICHD CRS": "40.714 -74.006", 
        "NYU Med. Ctr., Dept. of Medicine": "40.714 -74.006", 
        "North Shore-Long Island Jewish Health System, Dept. of Peds.": "40.801 -73.728", 
        "SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS": "40.653 -73.959", 
        "San Juan City Hosp. PR NICHD CRS": "18.466 -66.106", 
        "Schneider Children's Hosp., Div. of Infectious Diseases": "40.735 -73.688", 
        "St. Christopher's Hosp. for Children": "39.952 -75.164", 
        "Texas Children's Hosp. CRS": "29.76 -95.369", 
        "Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU": "29.951 -90.072", 
        "Tulane/LSU Maternal/Child CRS": "29.951 -90.072", 
        "UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS": "34.052 -118.244", 
        "UCSD Maternal, Child, and Adolescent HIV CRS": "32.715 -117.157", 
        "UCSF Pediatric AIDS CRS": "37.775 -122.419", 
        "UMDNJ - Robert Wood Johnson": "40.486 -74.452", 
        "UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases": "35.913 -79.056", 
        "Univ. Hosp. Ram\u00f3n Ruiz Arnau, Dept. of Peds.": "18.369 -66.166", 
        "Univ. of Illinois College of Medicine at Chicago, Dept. of Peds.": "41.878 -87.63", 
        "Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology": "39.29 -76.612", 
        "Univ. of Miami Ped. Perinatal HIV/AIDS CRS": "25.789 -80.226", 
        "Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS": "18.466 -66.106", 
        "Univ. of Rochester ACTG CRS": "43.161 -77.611", 
        "WNE Maternal Pediatric Adolescent AIDS CRS": "42.263 -71.802"
    }
}